FibroGen $FGEN- Thomas B. Neff, CEO, sold 37,798 shares in two separate transactions. Neff sold 18,899 shares at $17.56; and 18,899 shares at $17.94. Neff still owns 3,341,588 shares of FGEN.
Alder Biopharmaceuticals $ALDR- Mark James Litton, Chief Business Officer, sold 6,000 shares at $27.50. The total value of the transaction was $164,998. Litton still owns 26,000 shares of ALDR.
Spark Therapeutics $ONCE- Jeffrey D. Marrazzo, CEO, sold 5,000 shares at $54.66. The total value of the transaction was $273,306. Marrazzo still owns 230,000 shares of ONCE.
SciClone Pharmaceuticals $SCLN- Wilson Wai-Shun Cheung, CFO & Senior VP, Finance, sold 1,475 shares at $10. The total value of the transaction was $14,750. Cheung still owns 15,134 shares of SCLN.